rsz infection team

Greater Manchester NHS group leads way on infection study

Date: 18 January 2019

The Infectious Diseases research team at the Northern Care Alliance NHS Group (NCA) is leading the way on a major European study exploring Staphylococcus aureus and surgical site infections.

The NCA is one of six UK sites taking part in the ASPIRE-SSI study, with patients being recruited through pre-operative clinics at North Manchester General and the Royal Oldham Hospital.

The study is on the NIHR Clinical Research Network (CRN) Portfolio, supported locally by CRN Greater Manchester. 

The initial recruitment, which includes blood samples and swabs, is followed by phone calls during the 90 days after the patient’s surgery which makes it a time consuming and challenging study.

But the team is leading the way in the UK on recruitment with 186 patients consented since April 2018 and 77 currently enrolled in the study. The team has a close working relationship with the microbiology lab at the Royal Oldham where the very helpful staff have contributed to the success.

The Principal Investigator at the NCA is Dr Andy Ustianowski, CRN GM Infectious Disease specialty lead, and the ASPIRE-SSI study is expected to continue until April 2019 with the aim of recruiting 5,000 patients in Europe.

  • Summary:
    The Infectious Diseases research team at the Northern Care Alliance NHS Group (NCA) is leading the way on a major European study exploring Staphylococcus aureus and surgical site infections.
  • Include on homepage (one at a time):
  • Areas of the site this news is applicable to:
    Research
  • LCRN:
    Greater Manchester
  • Year of publication:
    2019
  • Specialty:
    Infectious Diseases and Microbiology
  • News filter:
    NIHR in your area


You may also be interested in